HEADER HYDROLASE 01-OCT-04 1XM2 TITLE CRYSTAL STRUCTURE OF HUMAN PRL-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE PHOSPHATASE; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: PRL-1; COMPND 5 EC: 3.1.3.48; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.G.JEONG,S.J.KIM,J.H.KIM,J.H.SON,S.E.RYU REVDAT 4 16-OCT-24 1XM2 1 REMARK REVDAT 3 10-NOV-21 1XM2 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1XM2 1 VERSN REVDAT 1 25-JAN-05 1XM2 0 JRNL AUTH D.G.JEONG,S.J.KIM,J.H.KIM,J.H.SON,M.R.PARK,S.M.LIM,T.S.YOON, JRNL AUTH 2 S.E.RYU JRNL TITL TRIMERIC STRUCTURE OF PRL-1 PHOSPHATASE REVEALS AN ACTIVE JRNL TITL 2 ENZYME CONFORMATION AND REGULATION MECHANISMS JRNL REF J.MOL.BIOL. V. 345 401 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 15571731 JRNL DOI 10.1016/J.JMB.2004.10.061 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 31124 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.296 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1546 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7080 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 92 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.370 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.17 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.930 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1XM2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-OCT-04. REMARK 100 THE DEPOSITION ID IS D_1000030500. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-MAY-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 6B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979, 0.9792, 0.9794, 0.9716 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31124 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : 0.07900 REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.26000 REMARK 200 R SYM FOR SHELL (I) : 0.26000 REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4K, SODIUM ACETATE, AMS, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.38000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A TRIMER. TWO TRIMERS EXIST IN REMARK 300 THE ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 ALA A 2 REMARK 465 ARG A 3 REMARK 465 MSE A 4 REMARK 465 ASN A 5 REMARK 465 ARG A 6 REMARK 465 PRO A 7 REMARK 465 ARG A 157 REMARK 465 LEU A 158 REMARK 465 ARG A 159 REMARK 465 PHE A 160 REMARK 465 LYS A 161 REMARK 465 ASP A 162 REMARK 465 SER A 163 REMARK 465 ASN A 164 REMARK 465 GLY A 165 REMARK 465 HIS A 166 REMARK 465 ARG A 167 REMARK 465 ASN A 168 REMARK 465 ASN A 169 REMARK 465 CYS A 170 REMARK 465 CYS A 171 REMARK 465 ILE A 172 REMARK 465 GLN A 173 REMARK 465 MSE B 1 REMARK 465 ALA B 2 REMARK 465 ARG B 3 REMARK 465 MSE B 4 REMARK 465 ASN B 5 REMARK 465 ARG B 6 REMARK 465 PRO B 7 REMARK 465 ARG B 157 REMARK 465 LEU B 158 REMARK 465 ARG B 159 REMARK 465 PHE B 160 REMARK 465 LYS B 161 REMARK 465 ASP B 162 REMARK 465 SER B 163 REMARK 465 ASN B 164 REMARK 465 GLY B 165 REMARK 465 HIS B 166 REMARK 465 ARG B 167 REMARK 465 ASN B 168 REMARK 465 ASN B 169 REMARK 465 CYS B 170 REMARK 465 CYS B 171 REMARK 465 ILE B 172 REMARK 465 GLN B 173 REMARK 465 MSE C 1 REMARK 465 ALA C 2 REMARK 465 ARG C 3 REMARK 465 MSE C 4 REMARK 465 ASN C 5 REMARK 465 ARG C 6 REMARK 465 PRO C 7 REMARK 465 ARG C 157 REMARK 465 LEU C 158 REMARK 465 ARG C 159 REMARK 465 PHE C 160 REMARK 465 LYS C 161 REMARK 465 ASP C 162 REMARK 465 SER C 163 REMARK 465 ASN C 164 REMARK 465 GLY C 165 REMARK 465 HIS C 166 REMARK 465 ARG C 167 REMARK 465 ASN C 168 REMARK 465 ASN C 169 REMARK 465 CYS C 170 REMARK 465 CYS C 171 REMARK 465 ILE C 172 REMARK 465 GLN C 173 REMARK 465 MSE D 1 REMARK 465 ALA D 2 REMARK 465 ARG D 3 REMARK 465 MSE D 4 REMARK 465 ASN D 5 REMARK 465 ARG D 6 REMARK 465 PRO D 7 REMARK 465 THR D 26 REMARK 465 ASN D 27 REMARK 465 ALA D 51 REMARK 465 THR D 52 REMARK 465 TYR D 53 REMARK 465 ARG D 157 REMARK 465 LEU D 158 REMARK 465 ARG D 159 REMARK 465 PHE D 160 REMARK 465 LYS D 161 REMARK 465 ASP D 162 REMARK 465 SER D 163 REMARK 465 ASN D 164 REMARK 465 GLY D 165 REMARK 465 HIS D 166 REMARK 465 ARG D 167 REMARK 465 ASN D 168 REMARK 465 ASN D 169 REMARK 465 CYS D 170 REMARK 465 CYS D 171 REMARK 465 ILE D 172 REMARK 465 GLN D 173 REMARK 465 MSE E 1 REMARK 465 ALA E 2 REMARK 465 ARG E 3 REMARK 465 MSE E 4 REMARK 465 ASN E 5 REMARK 465 ARG E 6 REMARK 465 PRO E 7 REMARK 465 ARG E 157 REMARK 465 LEU E 158 REMARK 465 ARG E 159 REMARK 465 PHE E 160 REMARK 465 LYS E 161 REMARK 465 ASP E 162 REMARK 465 SER E 163 REMARK 465 ASN E 164 REMARK 465 GLY E 165 REMARK 465 HIS E 166 REMARK 465 ARG E 167 REMARK 465 ASN E 168 REMARK 465 ASN E 169 REMARK 465 CYS E 170 REMARK 465 CYS E 171 REMARK 465 ILE E 172 REMARK 465 GLN E 173 REMARK 465 MSE F 1 REMARK 465 ALA F 2 REMARK 465 ARG F 3 REMARK 465 MSE F 4 REMARK 465 ASN F 5 REMARK 465 ARG F 6 REMARK 465 PRO F 7 REMARK 465 THR F 26 REMARK 465 ASN F 27 REMARK 465 ARG F 157 REMARK 465 LEU F 158 REMARK 465 ARG F 159 REMARK 465 PHE F 160 REMARK 465 LYS F 161 REMARK 465 ASP F 162 REMARK 465 SER F 163 REMARK 465 ASN F 164 REMARK 465 GLY F 165 REMARK 465 HIS F 166 REMARK 465 ARG F 167 REMARK 465 ASN F 168 REMARK 465 ASN F 169 REMARK 465 CYS F 170 REMARK 465 CYS F 171 REMARK 465 ILE F 172 REMARK 465 GLN F 173 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS C 15 N - CA - C ANGL. DEV. = -17.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 14 120.14 161.54 REMARK 500 PRO A 25 -168.41 -61.08 REMARK 500 TRP A 68 57.86 -118.29 REMARK 500 SER A 104 -139.36 -117.12 REMARK 500 ARG A 138 -81.90 -23.12 REMARK 500 LYS A 155 -76.83 -79.51 REMARK 500 TYR B 14 117.59 150.31 REMARK 500 THR B 29 3.89 -153.58 REMARK 500 CYS B 49 -165.24 -120.44 REMARK 500 TRP B 68 79.77 -117.36 REMARK 500 SER B 77 170.09 -59.00 REMARK 500 SER B 104 -158.53 -128.98 REMARK 500 ARG B 138 -76.18 -19.51 REMARK 500 LYS B 155 58.26 -153.67 REMARK 500 TYR C 14 118.36 156.01 REMARK 500 HIS C 23 -148.68 -93.58 REMARK 500 PRO C 25 102.22 -37.78 REMARK 500 THR C 26 173.59 -49.15 REMARK 500 ASN C 27 50.02 13.79 REMARK 500 ALA C 28 -17.13 54.55 REMARK 500 CYS C 49 -151.57 -113.47 REMARK 500 GLU C 50 87.88 -156.67 REMARK 500 TYR C 53 100.87 172.35 REMARK 500 ASP C 54 76.05 -62.36 REMARK 500 SER C 77 174.43 -59.43 REMARK 500 SER C 104 -167.86 -127.90 REMARK 500 ARG C 138 -76.09 -25.10 REMARK 500 LYS C 155 108.55 -59.49 REMARK 500 TYR D 14 119.69 163.76 REMARK 500 HIS D 23 -152.54 -85.63 REMARK 500 CYS D 49 -165.62 -108.49 REMARK 500 THR D 55 -9.52 -54.45 REMARK 500 TRP D 68 71.47 -118.78 REMARK 500 ASP D 71 144.08 -37.07 REMARK 500 GLU D 95 70.68 -115.92 REMARK 500 SER D 104 -156.85 -123.60 REMARK 500 PRO E 9 24.83 -68.94 REMARK 500 VAL E 10 106.90 -52.31 REMARK 500 TYR E 14 123.44 146.54 REMARK 500 THR E 52 0.74 -154.79 REMARK 500 SER E 104 -152.18 -130.95 REMARK 500 ARG E 138 -94.62 -25.77 REMARK 500 PRO F 9 43.89 -86.72 REMARK 500 TYR F 14 114.85 157.39 REMARK 500 HIS F 23 -169.87 -79.83 REMARK 500 THR F 29 48.28 -107.18 REMARK 500 CYS F 49 -160.69 -114.82 REMARK 500 TRP F 68 72.04 -115.98 REMARK 500 SER F 104 -151.76 -132.77 REMARK 500 ARG F 138 -74.02 -28.59 REMARK 500 REMARK 500 THIS ENTRY HAS 52 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 181 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 182 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 183 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 184 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 E 185 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 F 186 DBREF 1XM2 A 1 173 UNP Q93096 TP4A1_HUMAN 1 173 DBREF 1XM2 B 1 173 UNP Q93096 TP4A1_HUMAN 1 173 DBREF 1XM2 C 1 173 UNP Q93096 TP4A1_HUMAN 1 173 DBREF 1XM2 D 1 173 UNP Q93096 TP4A1_HUMAN 1 173 DBREF 1XM2 E 1 173 UNP Q93096 TP4A1_HUMAN 1 173 DBREF 1XM2 F 1 173 UNP Q93096 TP4A1_HUMAN 1 173 SEQADV 1XM2 MSE A 1 UNP Q93096 MET 1 MODIFIED RESIDUE SEQADV 1XM2 MSE A 4 UNP Q93096 MET 4 MODIFIED RESIDUE SEQADV 1XM2 MSE A 17 UNP Q93096 MET 17 MODIFIED RESIDUE SEQADV 1XM2 SER A 104 UNP Q93096 CYS 104 ENGINEERED MUTATION SEQADV 1XM2 MSE A 124 UNP Q93096 MET 124 MODIFIED RESIDUE SEQADV 1XM2 MSE A 156 UNP Q93096 MET 156 MODIFIED RESIDUE SEQADV 1XM2 MSE B 1 UNP Q93096 MET 1 MODIFIED RESIDUE SEQADV 1XM2 MSE B 4 UNP Q93096 MET 4 MODIFIED RESIDUE SEQADV 1XM2 MSE B 17 UNP Q93096 MET 17 MODIFIED RESIDUE SEQADV 1XM2 SER B 104 UNP Q93096 CYS 104 ENGINEERED MUTATION SEQADV 1XM2 MSE B 124 UNP Q93096 MET 124 MODIFIED RESIDUE SEQADV 1XM2 MSE B 156 UNP Q93096 MET 156 MODIFIED RESIDUE SEQADV 1XM2 MSE C 1 UNP Q93096 MET 1 MODIFIED RESIDUE SEQADV 1XM2 MSE C 4 UNP Q93096 MET 4 MODIFIED RESIDUE SEQADV 1XM2 MSE C 17 UNP Q93096 MET 17 MODIFIED RESIDUE SEQADV 1XM2 SER C 104 UNP Q93096 CYS 104 ENGINEERED MUTATION SEQADV 1XM2 MSE C 124 UNP Q93096 MET 124 MODIFIED RESIDUE SEQADV 1XM2 MSE C 156 UNP Q93096 MET 156 MODIFIED RESIDUE SEQADV 1XM2 MSE D 1 UNP Q93096 MET 1 MODIFIED RESIDUE SEQADV 1XM2 MSE D 4 UNP Q93096 MET 4 MODIFIED RESIDUE SEQADV 1XM2 MSE D 17 UNP Q93096 MET 17 MODIFIED RESIDUE SEQADV 1XM2 SER D 104 UNP Q93096 CYS 104 ENGINEERED MUTATION SEQADV 1XM2 MSE D 124 UNP Q93096 MET 124 MODIFIED RESIDUE SEQADV 1XM2 MSE D 156 UNP Q93096 MET 156 MODIFIED RESIDUE SEQADV 1XM2 MSE E 1 UNP Q93096 MET 1 MODIFIED RESIDUE SEQADV 1XM2 MSE E 4 UNP Q93096 MET 4 MODIFIED RESIDUE SEQADV 1XM2 MSE E 17 UNP Q93096 MET 17 MODIFIED RESIDUE SEQADV 1XM2 SER E 104 UNP Q93096 CYS 104 ENGINEERED MUTATION SEQADV 1XM2 MSE E 124 UNP Q93096 MET 124 MODIFIED RESIDUE SEQADV 1XM2 MSE E 156 UNP Q93096 MET 156 MODIFIED RESIDUE SEQADV 1XM2 MSE F 1 UNP Q93096 MET 1 MODIFIED RESIDUE SEQADV 1XM2 MSE F 4 UNP Q93096 MET 4 MODIFIED RESIDUE SEQADV 1XM2 MSE F 17 UNP Q93096 MET 17 MODIFIED RESIDUE SEQADV 1XM2 SER F 104 UNP Q93096 CYS 104 ENGINEERED MUTATION SEQADV 1XM2 MSE F 124 UNP Q93096 MET 124 MODIFIED RESIDUE SEQADV 1XM2 MSE F 156 UNP Q93096 MET 156 MODIFIED RESIDUE SEQRES 1 A 173 MSE ALA ARG MSE ASN ARG PRO ALA PRO VAL GLU VAL THR SEQRES 2 A 173 TYR LYS ASN MSE ARG PHE LEU ILE THR HIS ASN PRO THR SEQRES 3 A 173 ASN ALA THR LEU ASN LYS PHE ILE GLU GLU LEU LYS LYS SEQRES 4 A 173 TYR GLY VAL THR THR ILE VAL ARG VAL CYS GLU ALA THR SEQRES 5 A 173 TYR ASP THR THR LEU VAL GLU LYS GLU GLY ILE HIS VAL SEQRES 6 A 173 LEU ASP TRP PRO PHE ASP ASP GLY ALA PRO PRO SER ASN SEQRES 7 A 173 GLN ILE VAL ASP ASP TRP LEU SER LEU VAL LYS ILE LYS SEQRES 8 A 173 PHE ARG GLU GLU PRO GLY CYS CYS ILE ALA VAL HIS SER SEQRES 9 A 173 VAL ALA GLY LEU GLY ARG ALA PRO VAL LEU VAL ALA LEU SEQRES 10 A 173 ALA LEU ILE GLU GLY GLY MSE LYS TYR GLU ASP ALA VAL SEQRES 11 A 173 GLN PHE ILE ARG GLN LYS ARG ARG GLY ALA PHE ASN SER SEQRES 12 A 173 LYS GLN LEU LEU TYR LEU GLU LYS TYR ARG PRO LYS MSE SEQRES 13 A 173 ARG LEU ARG PHE LYS ASP SER ASN GLY HIS ARG ASN ASN SEQRES 14 A 173 CYS CYS ILE GLN SEQRES 1 B 173 MSE ALA ARG MSE ASN ARG PRO ALA PRO VAL GLU VAL THR SEQRES 2 B 173 TYR LYS ASN MSE ARG PHE LEU ILE THR HIS ASN PRO THR SEQRES 3 B 173 ASN ALA THR LEU ASN LYS PHE ILE GLU GLU LEU LYS LYS SEQRES 4 B 173 TYR GLY VAL THR THR ILE VAL ARG VAL CYS GLU ALA THR SEQRES 5 B 173 TYR ASP THR THR LEU VAL GLU LYS GLU GLY ILE HIS VAL SEQRES 6 B 173 LEU ASP TRP PRO PHE ASP ASP GLY ALA PRO PRO SER ASN SEQRES 7 B 173 GLN ILE VAL ASP ASP TRP LEU SER LEU VAL LYS ILE LYS SEQRES 8 B 173 PHE ARG GLU GLU PRO GLY CYS CYS ILE ALA VAL HIS SER SEQRES 9 B 173 VAL ALA GLY LEU GLY ARG ALA PRO VAL LEU VAL ALA LEU SEQRES 10 B 173 ALA LEU ILE GLU GLY GLY MSE LYS TYR GLU ASP ALA VAL SEQRES 11 B 173 GLN PHE ILE ARG GLN LYS ARG ARG GLY ALA PHE ASN SER SEQRES 12 B 173 LYS GLN LEU LEU TYR LEU GLU LYS TYR ARG PRO LYS MSE SEQRES 13 B 173 ARG LEU ARG PHE LYS ASP SER ASN GLY HIS ARG ASN ASN SEQRES 14 B 173 CYS CYS ILE GLN SEQRES 1 C 173 MSE ALA ARG MSE ASN ARG PRO ALA PRO VAL GLU VAL THR SEQRES 2 C 173 TYR LYS ASN MSE ARG PHE LEU ILE THR HIS ASN PRO THR SEQRES 3 C 173 ASN ALA THR LEU ASN LYS PHE ILE GLU GLU LEU LYS LYS SEQRES 4 C 173 TYR GLY VAL THR THR ILE VAL ARG VAL CYS GLU ALA THR SEQRES 5 C 173 TYR ASP THR THR LEU VAL GLU LYS GLU GLY ILE HIS VAL SEQRES 6 C 173 LEU ASP TRP PRO PHE ASP ASP GLY ALA PRO PRO SER ASN SEQRES 7 C 173 GLN ILE VAL ASP ASP TRP LEU SER LEU VAL LYS ILE LYS SEQRES 8 C 173 PHE ARG GLU GLU PRO GLY CYS CYS ILE ALA VAL HIS SER SEQRES 9 C 173 VAL ALA GLY LEU GLY ARG ALA PRO VAL LEU VAL ALA LEU SEQRES 10 C 173 ALA LEU ILE GLU GLY GLY MSE LYS TYR GLU ASP ALA VAL SEQRES 11 C 173 GLN PHE ILE ARG GLN LYS ARG ARG GLY ALA PHE ASN SER SEQRES 12 C 173 LYS GLN LEU LEU TYR LEU GLU LYS TYR ARG PRO LYS MSE SEQRES 13 C 173 ARG LEU ARG PHE LYS ASP SER ASN GLY HIS ARG ASN ASN SEQRES 14 C 173 CYS CYS ILE GLN SEQRES 1 D 173 MSE ALA ARG MSE ASN ARG PRO ALA PRO VAL GLU VAL THR SEQRES 2 D 173 TYR LYS ASN MSE ARG PHE LEU ILE THR HIS ASN PRO THR SEQRES 3 D 173 ASN ALA THR LEU ASN LYS PHE ILE GLU GLU LEU LYS LYS SEQRES 4 D 173 TYR GLY VAL THR THR ILE VAL ARG VAL CYS GLU ALA THR SEQRES 5 D 173 TYR ASP THR THR LEU VAL GLU LYS GLU GLY ILE HIS VAL SEQRES 6 D 173 LEU ASP TRP PRO PHE ASP ASP GLY ALA PRO PRO SER ASN SEQRES 7 D 173 GLN ILE VAL ASP ASP TRP LEU SER LEU VAL LYS ILE LYS SEQRES 8 D 173 PHE ARG GLU GLU PRO GLY CYS CYS ILE ALA VAL HIS SER SEQRES 9 D 173 VAL ALA GLY LEU GLY ARG ALA PRO VAL LEU VAL ALA LEU SEQRES 10 D 173 ALA LEU ILE GLU GLY GLY MSE LYS TYR GLU ASP ALA VAL SEQRES 11 D 173 GLN PHE ILE ARG GLN LYS ARG ARG GLY ALA PHE ASN SER SEQRES 12 D 173 LYS GLN LEU LEU TYR LEU GLU LYS TYR ARG PRO LYS MSE SEQRES 13 D 173 ARG LEU ARG PHE LYS ASP SER ASN GLY HIS ARG ASN ASN SEQRES 14 D 173 CYS CYS ILE GLN SEQRES 1 E 173 MSE ALA ARG MSE ASN ARG PRO ALA PRO VAL GLU VAL THR SEQRES 2 E 173 TYR LYS ASN MSE ARG PHE LEU ILE THR HIS ASN PRO THR SEQRES 3 E 173 ASN ALA THR LEU ASN LYS PHE ILE GLU GLU LEU LYS LYS SEQRES 4 E 173 TYR GLY VAL THR THR ILE VAL ARG VAL CYS GLU ALA THR SEQRES 5 E 173 TYR ASP THR THR LEU VAL GLU LYS GLU GLY ILE HIS VAL SEQRES 6 E 173 LEU ASP TRP PRO PHE ASP ASP GLY ALA PRO PRO SER ASN SEQRES 7 E 173 GLN ILE VAL ASP ASP TRP LEU SER LEU VAL LYS ILE LYS SEQRES 8 E 173 PHE ARG GLU GLU PRO GLY CYS CYS ILE ALA VAL HIS SER SEQRES 9 E 173 VAL ALA GLY LEU GLY ARG ALA PRO VAL LEU VAL ALA LEU SEQRES 10 E 173 ALA LEU ILE GLU GLY GLY MSE LYS TYR GLU ASP ALA VAL SEQRES 11 E 173 GLN PHE ILE ARG GLN LYS ARG ARG GLY ALA PHE ASN SER SEQRES 12 E 173 LYS GLN LEU LEU TYR LEU GLU LYS TYR ARG PRO LYS MSE SEQRES 13 E 173 ARG LEU ARG PHE LYS ASP SER ASN GLY HIS ARG ASN ASN SEQRES 14 E 173 CYS CYS ILE GLN SEQRES 1 F 173 MSE ALA ARG MSE ASN ARG PRO ALA PRO VAL GLU VAL THR SEQRES 2 F 173 TYR LYS ASN MSE ARG PHE LEU ILE THR HIS ASN PRO THR SEQRES 3 F 173 ASN ALA THR LEU ASN LYS PHE ILE GLU GLU LEU LYS LYS SEQRES 4 F 173 TYR GLY VAL THR THR ILE VAL ARG VAL CYS GLU ALA THR SEQRES 5 F 173 TYR ASP THR THR LEU VAL GLU LYS GLU GLY ILE HIS VAL SEQRES 6 F 173 LEU ASP TRP PRO PHE ASP ASP GLY ALA PRO PRO SER ASN SEQRES 7 F 173 GLN ILE VAL ASP ASP TRP LEU SER LEU VAL LYS ILE LYS SEQRES 8 F 173 PHE ARG GLU GLU PRO GLY CYS CYS ILE ALA VAL HIS SER SEQRES 9 F 173 VAL ALA GLY LEU GLY ARG ALA PRO VAL LEU VAL ALA LEU SEQRES 10 F 173 ALA LEU ILE GLU GLY GLY MSE LYS TYR GLU ASP ALA VAL SEQRES 11 F 173 GLN PHE ILE ARG GLN LYS ARG ARG GLY ALA PHE ASN SER SEQRES 12 F 173 LYS GLN LEU LEU TYR LEU GLU LYS TYR ARG PRO LYS MSE SEQRES 13 F 173 ARG LEU ARG PHE LYS ASP SER ASN GLY HIS ARG ASN ASN SEQRES 14 F 173 CYS CYS ILE GLN MODRES 1XM2 MSE A 17 MET SELENOMETHIONINE MODRES 1XM2 MSE A 124 MET SELENOMETHIONINE MODRES 1XM2 MSE A 156 MET SELENOMETHIONINE MODRES 1XM2 MSE B 17 MET SELENOMETHIONINE MODRES 1XM2 MSE B 124 MET SELENOMETHIONINE MODRES 1XM2 MSE B 156 MET SELENOMETHIONINE MODRES 1XM2 MSE C 17 MET SELENOMETHIONINE MODRES 1XM2 MSE C 124 MET SELENOMETHIONINE MODRES 1XM2 MSE C 156 MET SELENOMETHIONINE MODRES 1XM2 MSE D 17 MET SELENOMETHIONINE MODRES 1XM2 MSE D 124 MET SELENOMETHIONINE MODRES 1XM2 MSE D 156 MET SELENOMETHIONINE MODRES 1XM2 MSE E 17 MET SELENOMETHIONINE MODRES 1XM2 MSE E 124 MET SELENOMETHIONINE MODRES 1XM2 MSE E 156 MET SELENOMETHIONINE MODRES 1XM2 MSE F 17 MET SELENOMETHIONINE MODRES 1XM2 MSE F 124 MET SELENOMETHIONINE MODRES 1XM2 MSE F 156 MET SELENOMETHIONINE HET MSE A 17 8 HET MSE A 124 8 HET MSE A 156 8 HET MSE B 17 8 HET MSE B 124 8 HET MSE B 156 8 HET MSE C 17 8 HET MSE C 124 8 HET MSE C 156 8 HET MSE D 17 8 HET MSE D 124 8 HET MSE D 156 8 HET MSE E 17 8 HET MSE E 124 8 HET MSE E 156 8 HET MSE F 17 8 HET MSE F 124 8 HET MSE F 156 8 HET SO4 A 181 5 HET SO4 B 182 5 HET SO4 C 183 5 HET SO4 D 184 5 HET SO4 E 185 5 HET SO4 F 186 5 HETNAM MSE SELENOMETHIONINE HETNAM SO4 SULFATE ION FORMUL 1 MSE 18(C5 H11 N O2 SE) FORMUL 7 SO4 6(O4 S 2-) FORMUL 13 HOH *92(H2 O) HELIX 1 1 THR A 29 TYR A 40 1 12 HELIX 2 2 THR A 55 GLU A 61 1 7 HELIX 3 3 SER A 77 GLU A 95 1 19 HELIX 4 4 GLY A 109 GLY A 122 1 14 HELIX 5 5 LYS A 125 GLN A 135 1 11 HELIX 6 6 ASN A 142 TYR A 152 1 11 HELIX 7 7 THR B 29 TYR B 40 1 12 HELIX 8 8 ASP B 54 GLU B 61 1 8 HELIX 9 9 SER B 77 GLU B 95 1 19 HELIX 10 10 GLY B 109 GLY B 122 1 14 HELIX 11 11 LYS B 125 GLN B 135 1 11 HELIX 12 12 ASN B 142 TYR B 152 1 11 HELIX 13 13 THR C 29 TYR C 40 1 12 HELIX 14 14 ASP C 54 GLU C 61 1 8 HELIX 15 15 SER C 77 GLU C 95 1 19 HELIX 16 16 GLY C 109 GLY C 122 1 14 HELIX 17 17 LYS C 125 GLN C 135 1 11 HELIX 18 18 ASN C 142 TYR C 152 1 11 HELIX 19 19 THR D 29 GLY D 41 1 13 HELIX 20 20 THR D 55 GLU D 61 1 7 HELIX 21 21 SER D 77 GLU D 95 1 19 HELIX 22 22 GLY D 109 GLY D 122 1 14 HELIX 23 23 LYS D 125 GLN D 135 1 11 HELIX 24 24 ASN D 142 TYR D 152 1 11 HELIX 25 25 THR E 26 ALA E 28 5 3 HELIX 26 26 THR E 29 TYR E 40 1 12 HELIX 27 27 THR E 55 GLU E 61 1 7 HELIX 28 28 SER E 77 GLU E 95 1 19 HELIX 29 29 GLY E 109 GLY E 122 1 14 HELIX 30 30 LYS E 125 GLN E 135 1 11 HELIX 31 31 ASN E 142 TYR E 152 1 11 HELIX 32 32 LEU F 30 TYR F 40 1 11 HELIX 33 33 THR F 55 GLU F 61 1 7 HELIX 34 34 SER F 77 GLU F 95 1 19 HELIX 35 35 GLY F 109 GLY F 122 1 14 HELIX 36 36 LYS F 125 GLN F 135 1 11 HELIX 37 37 ASN F 142 TYR F 152 1 11 SHEET 1 A 5 VAL A 10 THR A 13 0 SHEET 2 A 5 ARG A 18 THR A 22 -1 O PHE A 19 N VAL A 12 SHEET 3 A 5 CYS A 99 HIS A 103 1 O VAL A 102 N LEU A 20 SHEET 4 A 5 VAL A 42 ARG A 47 1 N VAL A 46 O HIS A 103 SHEET 5 A 5 HIS A 64 ASP A 67 1 O HIS A 64 N ILE A 45 SHEET 1 B 5 VAL B 10 THR B 13 0 SHEET 2 B 5 ARG B 18 THR B 22 -1 O PHE B 19 N VAL B 12 SHEET 3 B 5 CYS B 99 HIS B 103 1 O VAL B 102 N LEU B 20 SHEET 4 B 5 VAL B 42 ARG B 47 1 N VAL B 46 O ALA B 101 SHEET 5 B 5 HIS B 64 ASP B 67 1 O HIS B 64 N ILE B 45 SHEET 1 C 5 VAL C 10 THR C 13 0 SHEET 2 C 5 ARG C 18 THR C 22 -1 O PHE C 19 N VAL C 12 SHEET 3 C 5 CYS C 99 HIS C 103 1 O VAL C 102 N LEU C 20 SHEET 4 C 5 VAL C 42 ARG C 47 1 N VAL C 46 O HIS C 103 SHEET 5 C 5 HIS C 64 ASP C 67 1 O HIS C 64 N ILE C 45 SHEET 1 D 5 VAL D 10 THR D 13 0 SHEET 2 D 5 ARG D 18 THR D 22 -1 O PHE D 19 N VAL D 12 SHEET 3 D 5 CYS D 99 HIS D 103 1 O VAL D 102 N LEU D 20 SHEET 4 D 5 VAL D 42 ARG D 47 1 N THR D 44 O ALA D 101 SHEET 5 D 5 HIS D 64 ASP D 67 1 O LEU D 66 N ARG D 47 SHEET 1 E 5 GLU E 11 THR E 13 0 SHEET 2 E 5 ARG E 18 THR E 22 -1 O PHE E 19 N VAL E 12 SHEET 3 E 5 CYS E 99 HIS E 103 1 O VAL E 102 N LEU E 20 SHEET 4 E 5 VAL E 42 ARG E 47 1 N VAL E 46 O ALA E 101 SHEET 5 E 5 HIS E 64 ASP E 67 1 O HIS E 64 N ILE E 45 SHEET 1 F 5 VAL F 10 THR F 13 0 SHEET 2 F 5 ARG F 18 THR F 22 -1 O ILE F 21 N VAL F 10 SHEET 3 F 5 CYS F 99 HIS F 103 1 O VAL F 102 N LEU F 20 SHEET 4 F 5 VAL F 42 ARG F 47 1 N VAL F 46 O ALA F 101 SHEET 5 F 5 HIS F 64 ASP F 67 1 O LEU F 66 N ARG F 47 LINK C ASN A 16 N MSE A 17 1555 1555 1.33 LINK C MSE A 17 N ARG A 18 1555 1555 1.33 LINK C GLY A 123 N MSE A 124 1555 1555 1.33 LINK C MSE A 124 N LYS A 125 1555 1555 1.33 LINK C LYS A 155 N MSE A 156 1555 1555 1.33 LINK C ASN B 16 N MSE B 17 1555 1555 1.33 LINK C MSE B 17 N ARG B 18 1555 1555 1.33 LINK C GLY B 123 N MSE B 124 1555 1555 1.33 LINK C MSE B 124 N LYS B 125 1555 1555 1.33 LINK C LYS B 155 N MSE B 156 1555 1555 1.33 LINK C ASN C 16 N MSE C 17 1555 1555 1.33 LINK C MSE C 17 N ARG C 18 1555 1555 1.33 LINK C GLY C 123 N MSE C 124 1555 1555 1.34 LINK C MSE C 124 N LYS C 125 1555 1555 1.33 LINK C LYS C 155 N MSE C 156 1555 1555 1.33 LINK C ASN D 16 N MSE D 17 1555 1555 1.33 LINK C MSE D 17 N ARG D 18 1555 1555 1.33 LINK C GLY D 123 N MSE D 124 1555 1555 1.33 LINK C MSE D 124 N LYS D 125 1555 1555 1.33 LINK C LYS D 155 N MSE D 156 1555 1555 1.33 LINK C ASN E 16 N MSE E 17 1555 1555 1.34 LINK C MSE E 17 N ARG E 18 1555 1555 1.33 LINK C GLY E 123 N MSE E 124 1555 1555 1.33 LINK C MSE E 124 N LYS E 125 1555 1555 1.33 LINK C LYS E 155 N MSE E 156 1555 1555 1.34 LINK C ASN F 16 N MSE F 17 1555 1555 1.34 LINK C MSE F 17 N ARG F 18 1555 1555 1.33 LINK C GLY F 123 N MSE F 124 1555 1555 1.33 LINK C MSE F 124 N LYS F 125 1555 1555 1.33 LINK C LYS F 155 N MSE F 156 1555 1555 1.34 CISPEP 1 TYR A 14 LYS A 15 0 -1.25 CISPEP 2 TYR B 14 LYS B 15 0 -1.51 CISPEP 3 TYR C 14 LYS C 15 0 -0.92 CISPEP 4 TYR D 14 LYS D 15 0 -0.71 CISPEP 5 TYR E 14 LYS E 15 0 -1.17 CISPEP 6 TYR F 14 LYS F 15 0 -1.71 SITE 1 AC1 8 SER A 104 VAL A 105 ALA A 106 GLY A 107 SITE 2 AC1 8 LEU A 108 GLY A 109 ARG A 110 HOH A 206 SITE 1 AC2 8 ASP B 72 SER B 104 VAL B 105 ALA B 106 SITE 2 AC2 8 GLY B 107 LEU B 108 GLY B 109 ARG B 110 SITE 1 AC3 7 SER C 104 VAL C 105 ALA C 106 GLY C 107 SITE 2 AC3 7 LEU C 108 GLY C 109 ARG C 110 SITE 1 AC4 6 SER D 104 ALA D 106 GLY D 107 LEU D 108 SITE 2 AC4 6 GLY D 109 ARG D 110 SITE 1 AC5 6 SER E 104 VAL E 105 ALA E 106 LEU E 108 SITE 2 AC5 6 GLY E 109 ARG E 110 SITE 1 AC6 7 SER F 104 VAL F 105 ALA F 106 GLY F 107 SITE 2 AC6 7 LEU F 108 GLY F 109 ARG F 110 CRYST1 59.290 84.760 122.180 90.00 99.79 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016866 0.000000 0.002910 0.00000 SCALE2 0.000000 0.011798 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008306 0.00000